<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Mon, 17 Nov 2025 11:07:00 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>EU Clears Path for Biosimilars in Diabetes &amp; Bone Health</title><link>https://www.medscape.com/viewarticle/eu-clears-path-biosimilars-diabetes-bone-health-2025a1000vxz?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>The EMAâ€™s CHMP has endorsed Ondibta for diabetes and Osqay for osteoporosis, a move that could broaden access to effective, lower-cost biologics acros...</description><pubDate>Mon, 17 Nov 2025 15:14:57 GMT</pubDate></item><item><title>European Regulator Greenlights New Pertussis Vaccine</title><link>https://www.medscape.com/viewarticle/european-regulator-greenlights-new-pertussis-vaccine-2025a1000vxh?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>The recombinant vaccine VacPertagen offers booster protection for adolescents and adults while delivering passive immunity to newborns via maternal im...</description><pubDate>Mon, 17 Nov 2025 14:36:47 GMT</pubDate></item><item><title>Rejected cGvHD Therapy Gets Second Look by EMA</title><link>https://www.medscape.com/viewarticle/rejected-cgvhd-therapy-gets-second-look-ema-2025a1000vxi?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>The EMA initially rejected Rezurock due to uncertainty over its clinical benefit, noting that the pivotal study had no comparator arm and permitted co...</description><pubDate>Mon, 17 Nov 2025 14:35:42 GMT</pubDate></item><item><title>Gemini Leads LLMs in Communicating AMR Health Advice</title><link>https://www.medscape.com/viewarticle/gemini-leads-llms-communicating-amr-health-advice-2025a1000vx1?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>A new study finds Gemini 1.0 delivers the most accurate and readable information on antimicrobial resistance, but experts warn that LLMs still need me...</description><pubDate>Mon, 17 Nov 2025 13:04:33 GMT</pubDate></item><item><title>US Advanced Breast Cancer Survival Up, Global Progress Lags</title><link>https://www.medscape.com/viewarticle/us-advanced-breast-cancer-survival-global-progress-lags-2025a1000vup?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>A real-world analysis of more than 60,000 patients in the US finds median survival increased by almost 7 months from 2011 to 2025, while a companion g...</description><pubDate>Mon, 17 Nov 2025 13:00:00 GMT</pubDate></item></channel></rss>